9 June 14:20
In Russia, in 2026, they plan to obtain permission to use two vaccines against glioblastoma. RIA Novosti reports this with reference to the head of the Federal Medical and Biological Agency Veronica Skvortsova.
According to her, the first vaccine will be a peptide vaccine and will be called Glyopept. Also, by the end of the year, the FMBA expects to receive permission to use an mRNA vaccine against glioblastoma. It will be called “Gliorna”.
In November, the agency reported that preclinical studies of vaccines against this disease were in the final stages.
Let us remind you that glioblastoma is considered one of the most dangerous types of brain tumors. It develops due to the uncontrolled division of glial cells that surround neurons.
Related links:
- Krasnoyarsk residents were told why hepatitis C is dangerous
- Krasnoyarsk scientists have proposed a non-traumatic test for monitoring bladder cancer
